SCHEMBL5147168

SCHEMBL5147168

NC(=O)c1ccc(-n2c3c(c4cc(Cl)ccc42)C(=O)CCC3)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 5/20 0.51
PTGS2 P35354 5/20 0.51
OPRM1 P35372 1/20 0.44
HDAC1 Q13547 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
RORC P51449 2/20 0.35
ROCK2 O75116 1/20 0.34
PIM1 P11309 1/20 0.34
PIM3 Q86V86 1/20 0.34
IP6K1 Q92551 1/20 0.34
CNR1 P21554 3/20 0.33
CNR2 P34972 1/20 0.33
HSP90AA1 P07900 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147078 0.90 HDAC1 (0.48) PTGS1PTGS2OPRM1HDAC1HDAC6
SCHEMBL4791814 0.90 PTGS1 (0.45) PTGS1PTGS2OPRM1HDAC1HDAC6
SCHEMBL14422451 0.88 PTGS1 (0.43) PTGS1PTGS2OPRM1HDAC1HDAC6
SCHEMBL5147074 0.87 PTGS2 (0.48) PTGS1PTGS2OPRM1HDAC1HDAC6
SCHEMBL5148480 0.85 PTGS1 (0.44) PTGS1PTGS2OPRM1HDAC1HDAC6
SCHEMBL5147126 0.79 HDAC1 (0.46) PTGS1PTGS2OPRM1HDAC1HDAC6
SCHEMBL5145477 0.77 HDAC1 (0.46) PTGS1PTGS2OPRM1HDAC1HDAC6
SCHEMBL5147102 0.77 HDAC1 (0.48) PTGS1PTGS2HDAC1HDAC6ALDH1A1
SCHEMBL5147135 0.76 HDAC1 (0.43) PTGS1PTGS2OPRM1HDAC1HDAC6
SCHEMBL4771960 0.75 CYP3A4 (0.43) PTGS1PTGS2OPRM1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 PTGS1 665/4885PTGS2 1882/4885OPRM1 2654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.